Rosanna Paciucci has completed her PhD from New York University Medical School, NY, USA and postdoctoral studies from University of Cantabria, Spain and later on at the Institut Municipal d’Investigacio Medica (IMIM), Barcelona, Spain. She is group leader of the Biomedical Research group in Urology at Vall d’Hebron Institut of Research, Barcelona, Spain. She has published more than 25 papers in high impact factor journals and has two patents. The major focus of her research is directed to understanding the biology of castration-resistant prostate cancer. Rosanna Paciucci has completed her PhD from New York University Medical School, NY, USA and postdoctoral studies from University of Cantabria, Spain and later on at the Institut Municipal d’Investigacio Medica (IMIM), Barcelona, Spain. She is group leader of the Biomedical Research group in Urology at Vall d’Hebron Institut of Research, Barcelona, Spain. She has published more than 25 papers in high impact factor journals and has two patents. The major focus of her research is directed to understanding the biology of castration-resistant prostate cancer.

Gastroenterology